PeopleBio is trading at 2800.00 as of the 18th of March 2025, a 0.54 percent increase since the beginning of the trading day. The stock's open price was 2785.0. PeopleBio has 50 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. The performance scores are derived for the period starting the 18th of December 2024 and ending today, the 18th of March 2025. Click here to learn more.
Although PeopleBio's alpha and beta are two of the key measurements used to evaluate PeopleBio's performance over the market, the standard measures of volatility play an important role as well.
The output start index for this execution was zero with a total number of output elements of sixty-one. PeopleBio Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe PeopleBio price patterns.
Our tools can tell you how much better you can do entering a position in PeopleBio without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Sign In To Macroaxis Now
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
PeopleBio financial ratios help investors to determine whether PeopleBio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PeopleBio with respect to the benefits of owning PeopleBio security.